Chemokine Receptor 2 Is a Theranostic Biomarker for Abdominal Aortic Aneurysms
JACC: Basic to Translational Science · 2025-07 · 10 (7) · 101250
DOI: 10.1016/j.jacbts.2025.02.010 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC: Basic to Translational Science, 2025-07. Verfasst von Santiago Elizondo-Benedetto und 24 weiteren Autor:innen. Beteiligte Einrichtung: Section of Vascular Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri, USA. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NIBIB NIH HHS, NIH.
Abstract (Originalsprache)
Abdominal aortic aneurysm (AAA) is a degenerative vascular disease with a high mortality upon rupture. There is no diagnosis to predict the rupture nor effective medical therapies to prevent rupture. Here we demonstrate that the C-C chemokine receptor type 2 (CCR2) is a theranostic biomarker for AAA. In rat AAA models, we determined the potential of a CCR2-targeted positron emission tomography radiotracer [64Cu]Cu-DOTA-ECL1i predicting AAA rupture. Using a CCR2 inhibitor, we observed the effective prevention of rupture in AAA rat models. In humans, CCR2 positron emission tomography showed intense radiotracer uptake along the AAA wall in patients while little signal was observed in healthy volunteers.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Section of Vascular Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.
- Department of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA.
- Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
- Sorbonne Université, INSERM, CNRS, Centre d'Immunologie et des Maladies Infectieuses, Cimi-Paris, Paris, France.
- Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.
- Department of Mathematics, Howard University, Washington, DC, USA.
Förderung
- NHLBI NIH HHS
- NIBIB NIH HHS
- NIH
- Mallinckrodt Institute of Radiology, School of Medicine, Washington University in St. Louis
- Alvin J. Siteman Cancer Center
Zitieren
APA
Elizondo-Benedetto, S., Sastriques-Dunlop, S., Detering, L., Arif, B., Heo, G. S., Sultan, D., Luehmann, H., Zhang, X., Gao, X., Bredemeyer, A., Zaghloul, M. S., Harrison, K., Thies, D., McDonald, L., Combadière, C., Lin, C. Y., Kang, Y., Zheng, J., Ippolito, J., …, & Liu, Y. (2025). Chemokine Receptor 2 Is a Theranostic Biomarker for Abdominal Aortic Aneurysms. JACC: Basic to Translational Science, 10(7), 101250. https://doi.org/10.1016/j.jacbts.2025.02.010
Vancouver
Elizondo-Benedetto S, Sastriques-Dunlop S, Detering L, Arif B, Heo GS, Sultan D, et al. Chemokine Receptor 2 Is a Theranostic Biomarker for Abdominal Aortic Aneurysms. JACC: Basic to Translational Science. 2025;10(7):101250. doi:10.1016/j.jacbts.2025.02.010
BibTeX
@article{ElizondoBenedetto2025,
author = {Elizondo-Benedetto, Santiago and Sastriques-Dunlop, Sergio and Detering, Lisa and Arif, Batool and Heo, Gyu Seong and Sultan, Deborah and Luehmann, Hannah and Zhang, Xiaohui and Gao, Xuefeng and Bredemeyer, Andrea and Zaghloul, Mohamed S and Harrison, Kitty and Thies, Dakkota and McDonald, Laura and Combadière, Christophe and Lin, Chieh-Yu and Kang, Yeona and Zheng, Jie and Ippolito, Joseph and Laforest, Richard and Lavine, Kory and Gropler, Robert J and English, Sean J and Zayed, Mohamed A and Liu, Yongjian},
title = {Chemokine Receptor 2 Is a Theranostic Biomarker for Abdominal Aortic Aneurysms},
journal = {JACC: Basic to Translational Science},
year = {2025},
volume = {10},
number = {7},
pages = {101250},
doi = {10.1016/j.jacbts.2025.02.010}
}
EUVIMED